EMR Tutorial Acute Coronary Syndrome



Similar documents
Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

HCC/RxHCC Risk Tutorial for SETMA

Educational Goals & Objectives

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Improving PCI Benchmark times in a Non-PCI World

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

Calculating the stage of Renal Disease

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

(You will use the login ID and password below to login through the first two websites.)

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Addendum to Clinical Review for NDA

If necessary, double-click the Zip icon to see the Excel file, then double-click the file to open it.

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

Priority setting for research in healthcare: an application of value of. information analysis to glycoprotein IIb/IIIa antagonists in non-st elevation

Ischemic Heart Disease: Angina Pectoris

A Comprehensive Strategy for Coordinating the Care for Patients with Coronary Artery Disease (CAD) and Other Chronic Medical Conditions

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

LEADING-EDGE Cardiovascular Care

6/14/2010. Clinical Decision Support: Applied Decision Aids in the Electronic Medical Record. Addressing high risk practices

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Main Effect of Screening for Coronary Artery Disease Using CT

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

Translating Science to Health Care: the Use of Predictive Models in Decision Making

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

Risk Adjustment Factor (RAF) RADV June 1 st 2016

Acute Coronary Syndrome

Heart Attack: What You Need to Know

CV Disease : A Major Threat to Public Health

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Remote Delivery of Cardiac Rehabilitation

Listen to your heart: Good Cardiovascular Health for Life

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Medical Decision Making

IC 3 : Improving Continuous Cardiac Care Quality Improvement in Practice

Physician and other health professional services

Cardiology EHR Specialty Content

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Cilostazol versus Clopidogrel after Coronary Stenting

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

NIHI Big Data in Healthcare Research Case Study

Documentation Guidelines for Physicians Interventional Pain Services

ACTION Registry GWTG Version 2.4

The Bioresorbable Vascular Stent Dr Albert Ko

Chest Pain. Acute Myocardial Infarction: Differential Diagnosis and Patient Management. Common complaint in ED. Wide range of etiologies

Leveraging EMR Data to Better Understand Local Market Potential and the Deployment of Commercial Resources

Perioperative Cardiac Evaluation

PREVENTION IN THE CLINICAL SETTING

Atrial Fibrillation An update on diagnosis and management

Redefining the NSTEACS pathway in London

Guidelines Most Significantly Affected Under ICD-10-CM. May 29, 2013

Atrial Fibrillation Management Across the Spectrum of Illness

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

Evaluation & Management. Guidelines. Presented by: Kristi A. Gutierrez CCS-P, CPC, CEMC

Double-click an appointment to view the details.

CDS Starter Kit: Diabetes f ollow-up care

None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)

Cardiovascular Nursing Board Certification Examinations Level I-V

How To Pass A Hearing Code

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

GENERAL HEART DISEASE KNOW THE FACTS

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code )

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Unity Point Health PROBLEM LISTS IN THE ELECTRONIC HEALTH RECORD

FFR CT : Clinical studies

Medicare Supplement plan application

Implementing a Prehospital 12-Lead Program

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

The American Heart Association released new resuscitation science and treatment guidelines on October 19, 2010.

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

Quality Improvement. Quantified. TM. Program Overview July, 2008

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, Participating Faculty

PARAMEDIC TRAINING CLINICAL OBJECTIVES

ANES-402 Overview PAIN MEDICINE EVALUATION & INTERVENTION. By Debra Kerrigan Fellowship Coordinator 2/23/2010

HOW TO CITE THIS ARTICLE:

KIH Cardiac Rehabilitation Program

University of Miami Clinical Enterprise Technologies

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

This tutorial provides an introduction to NextGen, the electronic health record used at Gardner Packard Children s Health Center.

ECG may be indicated for patients with cardiovascular risk factors

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

PARTI: HOW TO IMPORT A CUSTOM EXAM TEMPLATE FOR TOP ASaP PARTICIPATION

Heart Failure Outpatient Clinical Pathway

EXHIBIT H SETTLEMENT ELIGIBILITY CRITERIA. a) pharmacy records reflecting the dispensing of Bextra and/or Celebrex to the Class Member; or

Blue Care Network Physical & Occupational Therapy Utilization Management Guide Published 11/13/2012

Electronic Medical Records (EMR) Centricity EMR Updating the Patient Record

Coronary Heart Disease (CHD) Brief

EEI Networking Event 2011 Copyright 2011 Mobigator Technology Group. All rights reserved.

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

NextGen EHR: Clinic Password and User Preferences Setup in PROD

Transcription:

EMR Tutorial Acute Coronary Syndrome How to find the Acute Coronary Syndrome AAA Home Page 1 of 26

Master Tool Bar Icon When the Template button is clicked you will be presented with the preference list. If the Acute Coronary Syndrome template is listed as one of your preferences, select it. If it is not one of your preferences, select the All radio button and scroll down until you find it in the list. Then you may select the template by either double-clicking on the name or single click on the name (so that it is highlighted in blue) and then click the OK button. NOTE: For more on how to set up your preferences, Click Here Page 2 of 26

One of the most difficult and one of the most important differential diagnoses which confront physicians in the outpatient setting is the distinguishing between chronic stable angina and the acute coronary syndrome. The former is a relatively benign condition which can be safely and successfully treated in the outpatient setting. The latter is a potentially fatal condition which requires immediate intervention to decrease the mortality risk of the patient. This suite of templates in conjunction with the Angina Suite of Templates has been developed in order to aid the healthcare provider in making that distinction accurately and quickly. The Acute Coronary Syndrome Suite of Templates consists of the following templates: Master Acute Coronary Syndrome Q-Wave Evaluation Differential Dx NESTMI/Unstable Angina Treatment Q-Wave MI Treatment Page 3 of 26

The Master Acute Coronary Syndrome Template Content: The following statement begins the suite, Do not think of chest pain as rule out MI, but think rule out acute coronary syndrome (MI and Unstable Angina). The first button is entitled Goals. It contains six goals of the evaluation of the patient for ACS. They are: Page 4 of 26

The second button is entitled Definition. It states: In the first column of the Master Acute Coronary Syndrome template, the following then appears: Vital signs Framingham 10-yr CVD Risk Framingham 10-Yr Stroke Risk Hubbard Probability Severe Coronary Disease TIMI Risk Score Global Cardiovascular Risk Page 5 of 26

Page 6 of 26

In the second column, 10 Risk Factors are listed which increase the probability that the patient could be having the ACS. Page 7 of 26

In the third column, 22 lab tests are displayed which are relevant to the evaluation of the patient potentially with the ACS. There is a button entitled Check For New Labs which allows you to import the latest lab values for the evaluation. Page 8 of 26

In the fourth column are the navigation buttons followed by the button entitled Document, which when depressed creates a document for this suite of templates. Page 9 of 26

Q-Wave Template The full name of this template is Comparison of Q wave and non-q wave MI. Nine characteristics of a Q-Wave MI and 10 Characteristics of a Non-Q Wave MI are displayed. Page 10 of 26

Page 11 of 26

Evaluation Template Page 12 of 26

The full name of this template is, Key Diagnostic Items to be Elicited for Assessing Significant CAD in Patients with Chest Pain Suggestive of Acute Coronary Syndrome. There are ten parts to this template. They are explained below: The first two are: Time of Onset of Pain there is a place to document the date and time of onset of the pain. Page 13 of 26

Duration and persistence of Pain there is a place to document how long the pain has lasted. The next two are: Character of Pain there are two buttons here which link you to the Angina Suite of templates for Type of Chest Pain and Class of Angina. For more information on Angina, Click Here. Associated Symptoms. four angina equivalents are displayed so that you can note them if they are present. The next two are: History of AMI or Invasive Procedures there is a link here to the Cardiac History Age and Gender these two elements are displayed automatically Page 14 of 26

Associated Risk Factors there is a place to document the presence of the five major risk factors for coronary artery disease Drug Use if patient s use or non-use of elicit drugs is automatically noted from the History template. A link to the List of Elicit Drugs in the patient s History is present here Page 15 of 26

Physical Examination this lists the Physical Findings suggestive of CAD and Signs/cause of secondary unstable angina. Next there is: ECG there is a link to the ECG Report from the Procedures template in NextGen. Page 16 of 26

Differential Diagnosis Template This is a pop-up which displays other potential causes of the pain which is commonly associated with the Acute Coronary Syndrome. Page 17 of 26

NESTIMI and Unstable Angina Treatment This template begins with the statement, Once unstable angina or non-set Segment has been identified, standard anti-ischemic treatments should be initiated. The template then displays 15 standard anti-ischemic treatments which can be initiated. Two of these Calcium Channel Blockers and Thrombolytic Therapy are not generally used with unstable angina and/or non-st-segment elevation MI. All of the treatments which are in blue have links to documents which give more information about each of these treatments. Page 18 of 26

Under the navigation button to the right there are three information documents: AHA Antiplatelet Recommendations AHA Anticoagulant Recommendations Glycoprotein Trials Q-Wave MI Treatment Template At the top of this template is the statement, Glycoprotein IIb/IIIa therapy is recommended in moderate to high-risk patients. The instruction is then given, Select one of the following options Is Cath lab treatment planned within 12 hours? Page 19 of 26

Is the patient to receive medical management ONLY or is cath lab treatment postponed for more than 123 hours? Page 20 of 26

At the bottom of this template, there are five links: Monitoring and Assessment Page 21 of 26

Medications this is an electronic PDR for 9 categories of medications which are used in the treatment of Acute Coronary Syndrome. Page 22 of 26

Complications in Q-Wave IM Page 23 of 26

Treatment Recommendations Page 24 of 26

EKG Changes Page 25 of 26

Document this generates the summary of the use of this suite of templates. Page 26 of 26